Ryvu Therapeutics SA had a revenue of 15.07M in the quarter ending Sep 30, 2024, with -4.27%. This bring the company's revenue in the last twelve months to 63.62M, Decreased 5.00%. In the fiscal year ending Dec 31, 2023, Ryvu Therapeutics SA had annual revenue of 46.86M with 20.76% growth.